MindMed holds Analyst Day focused on MM-120 for GAD; no specific data disclosed

Definium Therapeutics, Inc.

Analyst Day held June 20, 2023 in New York, NY.
Presentation centered on MM-120 program for generalized anxiety disorder (GAD).
Exhibit 99.1 filed but contains only cover page; substantive slides not included.
No clinical results, financial guidance, or milestones announced in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.